An Open, Multi-center Clinical Study of Combination Therapy With Tenofovir Disoproxil Fumarate and Peginterferon Alpha 2a in Nucleos(t)Ide Analogs Experienced Patients With HBV Related Hepatic Fibrosis
Latest Information Update: 02 Aug 2023
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatic fibrosis; Hepatitis B
- Focus Therapeutic Use
Most Recent Events
- 17 Jan 2020 Planned End Date changed from 30 Jun 2023 to 30 Jul 2023.
- 17 Jan 2020 Planned primary completion date changed from 30 Jun 2021 to 30 Jul 2021.
- 17 Jan 2020 Status changed from not yet recruiting to recruiting.